Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04557449
Title Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (CDK4)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

prostate adenocarcinoma

liposarcoma

lung adenocarcinoma

colorectal adenocarcinoma

progesterone-receptor positive breast cancer

estrogen-receptor positive breast cancer

Advanced Solid Tumor

Therapies

Letrozole + PF-07220060

Fulvestrant + PF-07220060

PF-07220060

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.